Walmart Extends Use of the Inovalon ONE® Platform
June 24 2021 - 6:55AM
Inovalon (Nasdaq: INOV), a leading provider of cloud-based
platforms empowering data-driven healthcare, today announced an
expansion and extension of the long-term engagement with Walmart
(NYSE: WMT) to provide cloud-based capabilities through the
Inovalon ONE® Platform in its extensive network of pharmacies
nationwide as part of its data-driven strategy to improve outcomes
and economics for its customers.
Under the agreement, Walmart will extend its
engagement into 2028 and will look to expand its use of Inovalon’s
cloud-based capabilities through the Inovalon ONE® Platform by
extending the use of ScriptMed® Cloud to empower the clinical care
management of complex patient populations served by Walmart’s
extensive nationwide network of retail pharmacies and to add
additional advanced Inovalon ONE® Platform functionality.
The broader Inovalon and Walmart engagement was
initiated in 2020 with the implementation of Inovalon’s ScriptMed®
Cloud offering, a configuration of the Inovalon ONE® Platform
designed to combine analytically driven care protocols with
superior quality, operational processes, and cost efficiencies.
“We are committed to a patient-centric approach
to dispensing medicine that makes it easy, convenient and fast for
our customers to get the medications they need to improve their
health,” said Mike Adloo, senior director of Health & Wellness,
Walmart.
“Walmart has an impressive track record of
innovative approaches to serving their customers, which is
providing measurable value to the marketplace,” said Keith
Dunleavy, M.D., chief executive officer of Inovalon. “We are
honored to work with Walmart and are eager to further contribute to
their mission of delivering quality care with the Inovalon ONE®
Platform.”
About Inovalon
Inovalon is a leading provider of cloud-based
platforms empowering data-driven healthcare. Through the Inovalon
ONE® Platform, Inovalon brings to the marketplace a national-scale
capability to interconnect with the healthcare ecosystem, aggregate
and analyze data in real time, and empower the application of
resulting insights to drive meaningful impact at the point of care.
Leveraging its Platform, unparalleled proprietary datasets, and
industry-leading subject matter expertise, Inovalon enables better
care, efficiency, and financial performance across the healthcare
ecosystem. From health plans and provider organizations, to
pharmaceutical, medical device, and diagnostics companies,
Inovalon’s unique achievement of value is delivered through the
effective progression of “Turning Data into Insight, and Insight
into Action®.” Supporting thousands of customers, including all 25
of the top 25 U.S. health plans, all 25 of the top 25 global pharma
companies, 24 of the top 25 U.S. healthcare provider systems, and
many of the leading pharmacy organizations, device manufacturers,
and other healthcare industry constituents, Inovalon’s technology
platforms and analytics are informed by data pertaining to more
than one million physicians, 580,000 clinical facilities, 336
million Americans, and 62 billion medical events. For more
information, visit www.inovalon.com.
Contact:
Kim E. Collins Senior Vice President, Corporate
Communicationskcollins@inovalon.com301-809-4000 x1473
Hulus AlpayVice President, Investor
Relationshalpay@inovalon.com301-809-4000 x1237
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Apr 2024 to May 2024
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From May 2023 to May 2024